Therapeutic Advances in Cardiovascular Disease

Scope & Guideline

Unlocking the Future of Cardiovascular Treatments

Introduction

Delve into the academic richness of Therapeutic Advances in Cardiovascular Disease with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1753-9447
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationTHER ADV CARDIO DIS / Ther. Adv. Cardiovasc. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Cardiovascular Disease' focuses on advancing the understanding and treatment of cardiovascular diseases through innovative research and clinical studies. Its scope encompasses a wide range of topics within cardiovascular medicine, emphasizing both therapeutic interventions and the underlying mechanisms of cardiovascular pathologies.
  1. Cardiovascular Interventions:
    Research focused on various interventional techniques, including catheter-based therapies, surgical procedures, and novel technologies aimed at improving patient outcomes in cardiovascular disease.
  2. Pharmacotherapy and Drug Development:
    Exploration of pharmacological treatments for cardiovascular conditions, including studies on the efficacy, safety, and novel uses of existing medications as well as the development of new therapeutic agents.
  3. Pathophysiology and Mechanistic Studies:
    Investigations into the underlying biological mechanisms of cardiovascular diseases, including genetic, molecular, and cellular aspects that contribute to disease progression and treatment responses.
  4. Epidemiology and Public Health:
    Studies assessing the prevalence, risk factors, and outcomes of cardiovascular diseases across different populations, providing insights into health disparities and public health initiatives.
  5. Clinical Outcomes and Quality of Life:
    Research aimed at understanding the impact of cardiovascular diseases on patients' quality of life, including studies on outcomes following treatments and interventions.
Recent publications in 'Therapeutic Advances in Cardiovascular Disease' indicate a shift towards exploring innovative therapeutic strategies and the integration of personalized medicine in cardiovascular care. The following themes have emerged as particularly relevant and are gaining traction in the field.
  1. Genomics and Personalized Medicine:
    An increasing focus on genetic factors influencing cardiovascular disease and treatment responses, including studies on gene polymorphisms and microRNA interactions, highlights the trend towards personalized medicine.
  2. Impact of Lifestyle and Nutrition:
    Research examining the role of dietary factors and lifestyle changes in cardiovascular health is gaining prominence, indicating a broader understanding of prevention strategies beyond pharmacotherapy.
  3. Telemedicine and Remote Monitoring:
    Emerging themes related to the use of telemedicine and digital health technologies for cardiovascular disease management have gained attention, particularly in light of the COVID-19 pandemic, suggesting a shift towards more accessible healthcare models.
  4. Long-Term Outcomes and Quality of Care:
    There is a growing emphasis on the long-term outcomes of treatments and interventions in cardiovascular care, with studies increasingly focusing on quality of life and patient-centered metrics.

Declining or Waning

While the journal has a broad focus, certain themes that were once prominent appear to be declining in frequency or importance based on recent publications. This may reflect shifts in research priorities or advancements in technology and treatment options.
  1. Traditional Risk Factors:
    Research focusing solely on traditional cardiovascular risk factors such as hypertension and hyperlipidemia seems to be waning, as more recent studies emphasize broader and more holistic approaches to cardiovascular health.
  2. Invasive Diagnostic Procedures:
    There has been a noticeable decline in studies centered on invasive diagnostic techniques in favor of non-invasive imaging and biomarker identification, reflecting advancements in diagnostic technology.
  3. Acute Coronary Syndrome Management:
    While still relevant, specific studies exclusively addressing acute coronary syndrome management are less frequent, possibly due to a shift towards more comprehensive approaches that include long-term management and preventive strategies.

Similar Journals

European Journal of Preventive Cardiology

Championing excellence in preventive cardiology research.
Publisher: OXFORD UNIV PRESSISSN: 2047-4873Frequency: 18 issues/year

The European Journal of Preventive Cardiology, published by Oxford University Press, is a leading international journal dedicated to the field of cardiology and cardiovascular medicine. With an impact factor that underscores its prestige—ranking in the top quartile (Q1) of both cardiology and epidemiology categories—the journal serves as a critical resource for researchers and practitioners seeking to advance their understanding of preventive strategies in cardiovascular health. Since its inception in 1999, it has provided a platform for high-quality research and reviews that address the epidemiology of cardiovascular diseases, risk factor management, and innovative prevention methodologies. Notably, it currently ranks #21 out of 387 in Medicine - Cardiology and #13 out of 148 in Medicine - Epidemiology according to Scopus, highlighting its influential position in these essential biomedical fields. The journal also provides open access options, allowing both readers and authors the opportunity to engage with groundbreaking research and enhance the dissemination of knowledge. With a commitment to excellence, the European Journal of Preventive Cardiology is an invaluable asset for those dedicated to the prevention of cardiovascular diseases.

PROGRESS IN CARDIOVASCULAR DISEASES

Pioneering Research for a Healthier Heart
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

AMERICAN HEART JOURNAL

Pioneering Research for a Healthier Heart
Publisher: MOSBY-ELSEVIERISSN: 0002-8703Frequency: 12 issues/year

AMERICAN HEART JOURNAL, published by MOSBY-ELSEVIER, stands at the forefront of cardiovascular research, encompassing a vast array of studies focused on heart health, cardiology, and related medical therapies. Established in 1925 and set to continue its legacy into 2024, this esteemed journal holds a prestigious Q1 ranking in the category of Cardiology and Cardiovascular Medicine, reflecting its commitment to quality and significant influence in the field, as evidenced by its 85th percentile ranking in Scopus. With a dedicated readership of researchers, clinicians, and students, the journal serves as a critical platform for sharing groundbreaking findings, innovative techniques, and comprehensive reviews that strive to advance cardiovascular science. Although it does not currently offer open access, the AMERICAN HEART JOURNAL remains an indispensable resource for anyone invested in the evolution and improvement of heart health.

Journal of the American Heart Association

Fostering Global Collaboration for Heart Health Solutions
Publisher: WILEYISSN: Frequency: 24 issues/year

The Journal of the American Heart Association, published by WILEY, serves as a premier platform for advancing cardiovascular medicine through its commitment to open access, fostering global dissemination of cutting-edge research since 2012. It proudly holds a prestigious position within the top quartile (Q1) in the categories of Cardiology and Cardiovascular Medicine, as evidenced by its Scopus ranking of #49 out of 387 journals, placing it in the 87th percentile. With a focus on innovative studies and transformative findings, this journal is essential for cardiologists, researchers, and healthcare professionals seeking to stay at the forefront of cardiovascular knowledge. The journal aims to bridge the gap between basic science and clinical practice, presenting findings that shape the future of heart health treatment and prevention. As a resource for academic and clinical communities alike, the Journal of the American Heart Association is dedicated to enhancing the understanding and treatment of cardiovascular diseases globally.

Journal fur Kardiologie

Connecting Professionals with Essential Cardiology Insights.
Publisher: KRAUSE & PACHERNEGG GMBHISSN: 1024-0098Frequency: 12 issues/year

The Journal fur Kardiologie, published by KRAUSE & PACHERNEGG GMBH, is a pivotal resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 1024-0098 and an E-ISSN of 1680-936X, this journal has played a significant role in disseminating valuable research and clinical studies from 1998 until its coverage discontinuation in Scopus in 2017. Despite its Scopus rank being relatively low at #316/324 in its category, it continues to serve as a platform for emerging cardiology research. The journal’s scope encompasses various aspects of cardiovascular health, providing insights that are crucial for researchers, professionals, and students alike seeking to advance their knowledge and practice in cardiology. While the journal is not open access, its contributions to the field are essential for those looking to stay informed about the latest developments in cardiovascular medicine.

Revista Portuguesa de Cardiologia

Exploring innovative solutions in cardiology since 1970.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Nepalese Heart Journal

Bridging Local Insights with Global Innovations
Publisher: CARDIAC SOC NEPALISSN: 2091-2978Frequency: 1 issue/year

Nepalese Heart Journal, published by the CARDIAC SOC NEPAL, serves as a premier platform for disseminating knowledge in the field of cardiology and cardiovascular health. With an ISSN of 2091-2978, this journal aims to bridge the gap between researchers, clinicians, and academicians by presenting high-quality, peer-reviewed articles that address clinical practices, innovative research, and emerging trends in heart disease management, especially within the context of Nepal and the surrounding region. Although it operates under a traditional publishing model, its commitment to excellence aids in reinforcing the scientific discourse in an area critical to public health. The journal is a valuable resource for professionals and students alike who are focused on advancing their understanding of cardiology and its implications for health policy and practice. Exploring the intersections of local challenges and global advancements in heart health, the Nepalese Heart Journal is poised to contribute meaningfully to the evolving landscape of cardiovascular research.

Minerva Cardiology and Angiology

Pioneering insights in cardiovascular medicine.
Publisher: EDIZIONI MINERVA MEDICAISSN: 2724-5683Frequency: 6 issues/year

Minerva Cardiology and Angiology, published by EDIZIONI MINERVA MEDICA, is a prominent journal in the field of cardiology and cardiovascular medicine, with an ISSN of 2724-5683 and E-ISSN of 2724-5772. Established in 2021, this journal aims to foster the dissemination of cutting-edge research, clinical practice guidelines, and innovative methodologies relevant to cardiovascular health. As of 2023, it holds a commendable Q3 quartile rank in its category, reflecting its growing influence within the scientific community. The journal is indexed in Scopus, where it ranks #221 out of 387 in its field, placing it in the 43rd percentile overall. Although it currently does not offer Open Access options, articles published in Minerva Cardiology and Angiology contribute significantly to ongoing discussions and advancements in heart and vascular health. The journal serves as an invaluable resource for researchers, healthcare professionals, and students seeking to stay informed on the latest developments in cardiology.

Indian Heart Journal

Pioneering Insights in Cardiovascular Medicine
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

Cardiovascular Diagnosis and Therapy

Elevating Standards in Cardiovascular Medicine and Research
Publisher: AME PUBLISHING COMPANYISSN: 2223-3652Frequency: 6 issues/year

Cardiovascular Diagnosis and Therapy, an esteemed journal in the field of Cardiology and Cardiovascular Medicine, is published by AME PUBLISHING COMPANY, based in Hong Kong, China. With an ISSN of 2223-3652 and an E-ISSN of 2223-3660, this open-access journal aims to present cutting-edge research that significantly advances diagnostic and therapeutic practices in cardiovascular health. Recognized for its impact, it holds a 2023 category quartile ranking of Q2 and is positioned at rank #124 out of 387 in Scopus, reflecting its noteworthy contribution to medical literature with a percentile of 68th. The journal welcomes contributions that span various aspects of cardiovascular research, including clinical trials, epidemiological studies, and innovative therapeutic approaches, making it a vital resource for researchers, practitioners, and students alike, committed to improving cardiovascular care.